We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
AusPAR: Maviret
Australian Public Assessment Report
Device/Product Name
Maviret
Active ingredients
Glecaprevir and pibrentasvir
AusPAR Date
Published
Sponsor
Submission Number
PM-2020-06602-1-2
Submission Type
Major variation and extension of indication
Decision
Approved